Claudio Celeghini

2.8k total citations
73 papers, 2.3k citations indexed

About

Claudio Celeghini is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Claudio Celeghini has authored 73 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 20 papers in Oncology and 19 papers in Immunology. Recurrent topics in Claudio Celeghini's work include Cell death mechanisms and regulation (14 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Platelet Disorders and Treatments (9 papers). Claudio Celeghini is often cited by papers focused on Cell death mechanisms and regulation (14 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Platelet Disorders and Treatments (9 papers). Claudio Celeghini collaborates with scholars based in Italy, United States and United Kingdom. Claudio Celeghini's co-authors include Giorgio Zauli, Paola Secchiero, Silvano Capitani, Davide Gibellini, Erika Rimondi, E. Melloni, Alessandra Bassini, Lorenzo Monasta, Raffaella Bosco and Arianna Gonelli and has published in prestigious journals such as Blood, The Journal of Immunology and Diabetes.

In The Last Decade

Claudio Celeghini

72 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudio Celeghini Italy 26 1.3k 621 497 391 358 73 2.3k
Didier Grillot United States 26 1.5k 1.2× 976 1.6× 634 1.3× 355 0.9× 286 0.8× 39 2.7k
Michèle Sabbah France 30 1.6k 1.3× 352 0.6× 962 1.9× 544 1.4× 91 0.3× 81 2.7k
Stavroula Baritaki Greece 31 1.5k 1.2× 492 0.8× 715 1.4× 571 1.5× 85 0.2× 96 2.6k
Françoise Porteu France 26 1.3k 1.0× 887 1.4× 533 1.1× 272 0.7× 603 1.7× 51 2.6k
Evelyn Orsó Germany 29 2.5k 2.0× 936 1.5× 1.7k 3.5× 572 1.5× 187 0.5× 62 5.0k
Yoshimoto Katsura Japan 30 1.3k 1.0× 3.1k 5.0× 729 1.5× 181 0.5× 782 2.2× 72 4.6k
Matthias Germer Germany 12 1.6k 1.2× 800 1.3× 376 0.8× 370 0.9× 194 0.5× 16 2.2k
Antonella Naldini Italy 32 964 0.8× 584 0.9× 389 0.8× 493 1.3× 483 1.3× 97 2.7k
Sara Martínez‐Martínez Spain 25 1.3k 1.0× 518 0.8× 343 0.7× 303 0.8× 78 0.2× 36 2.2k
Xiyun Deng China 32 1.6k 1.2× 736 1.2× 1.2k 2.4× 903 2.3× 87 0.2× 95 3.4k

Countries citing papers authored by Claudio Celeghini

Since Specialization
Citations

This map shows the geographic impact of Claudio Celeghini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Celeghini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Celeghini more than expected).

Fields of papers citing papers by Claudio Celeghini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Celeghini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Celeghini. The network helps show where Claudio Celeghini may publish in the future.

Co-authorship network of co-authors of Claudio Celeghini

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Celeghini. A scholar is included among the top collaborators of Claudio Celeghini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Celeghini. Claudio Celeghini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Casciano, Fabio, Claudio Celeghini, Lorenzo Caruso, et al.. (2024). Retinal Alterations Predict Early Prodromal Signs of Neurodegenerative Disease. International Journal of Molecular Sciences. 25(3). 1689–1689. 11 indexed citations
3.
Marcuzzi, Annalisa, et al.. (2023). Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations. International Journal of Molecular Sciences. 24(4). 3739–3739. 56 indexed citations
4.
Rimondi, Erika, E. Melloni, Arianna Romani, et al.. (2021). Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors. Current Oncology. 28(4). 2439–2451. 5 indexed citations
5.
Bernardi, Stella, Rebecca Voltan, Erika Rimondi, et al.. (2019). TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets?. Clinical Science. 133(10). 1145–1166. 23 indexed citations
6.
Marcuzzi, Annalisa, Claudia Loganes, Erica Valencic, et al.. (2018). Neuronal Dysfunction Associated with Cholesterol Deregulation. International Journal of Molecular Sciences. 19(5). 1523–1523. 11 indexed citations
7.
Tisato, Veronica, Stefania Gallo, E. Melloni, et al.. (2018). TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress. Mediators of Inflammation. 2018. 1–8. 10 indexed citations
8.
Ultimo, Simona, Carolina Simioni, Alberto M. Martelli, et al.. (2017). PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines. Oncotarget. 8(14). 23213–23227. 13 indexed citations
9.
Marcuzzi, Annalisa, Elisa Piscianz, Marina Zweyer, et al.. (2016). Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology. International Journal of Molecular Sciences. 17(3). 365–365. 19 indexed citations
10.
Zauli, Giorgio, Claudio Celeghini, Lorenzo Monasta, et al.. (2014). Soluble TRAIL is present at high concentrations in seminal plasma and promotes spermatozoa survival. Reproduction. 148(2). 191–198. 6 indexed citations
11.
Tisato, Veronica, et al.. (2013). MDM2 Non-Genotoxic Inhibitors as Innovative Therapeutic Approaches for the Treatment of Pediatric Malignancies. Current Medicinal Chemistry. 20(17). 2226–2236. 4 indexed citations
12.
Secchiero, Paola, Raffaella Bosco, Claudio Celeghini, & Giorgio Zauli. (2011). Recent Advances in the Therapeutic Perspectives of Nutlin-3. Current Pharmaceutical Design. 17(6). 569–577. 133 indexed citations
13.
Macor, Paolo, et al.. (2008). An Update on the Xenograft and Mouse Models Suitable for Investigating New Therapeutic Compounds for the Treatment of B-Cell Malignancies. Current Pharmaceutical Design. 14(21). 2023–2039. 15 indexed citations
14.
Secchiero, Paola, Federica Corallini, Assunta Pandolfi, et al.. (2006). An Increased Osteoprotegerin Serum Release Characterizes the Early Onset of Diabetes Mellitus and May Contribute to Endothelial Cell Dysfunction. American Journal Of Pathology. 169(6). 2236–2244. 121 indexed citations
15.
Secchiero, Paola, Elisa Barbarotto, Arianna Gonelli, et al.. (2005). Potential Pathogenetic Implications of Cyclooxygenase-2 Overexpression in B Chronic Lymphoid Leukemia Cells. American Journal Of Pathology. 167(6). 1599–1607. 44 indexed citations
16.
Gibellini, Davide, Maria Carla Re, Cristina Ponti, et al.. (2001). Extracellular Tat activates c‐fos promoter in low serum‐starved CD4+ T cells. British Journal of Haematology. 112(3). 663–670. 11 indexed citations
17.
Marchisio, Marco, Valeria Bertagnolo, Claudio Celeghini, et al.. (1999). Selective modulation of specific protein kinase C (PKC) isoforms in primary human megakaryocytic vs. erythroid cells. The Anatomical Record. 255(1). 7–14. 13 indexed citations
18.
Gibellini, Davide, Claudio Celeghini, Paola Secchiero, et al.. (1997). The engagement of CD4 surface antigen in the HEL haemopoietic cell line up‐regulates the transforming growth factor‐β1 (TGF‐β1) promoter activity. British Journal of Haematology. 97(3). 571–578. 4 indexed citations
19.
Gibellini, Davide, Giorgio Zauli, Maria Carla Re, et al.. (1995). In Situ Polymerase Chain Reaction Technique Revealed by Flow Cytometry as a Tool for Gene Detection. Analytical Biochemistry. 228(2). 252–258. 13 indexed citations
20.
Zauli, Giorgio, Marco Marchisio, Valeria Bertagnolo, Claudio Celeghini, & Silvano Capitani. (1994). HIV-1 TAT PROTEIN SUPPRESSES THE NERVE GROWTH-FACTOR (NGF)-MEDIATED DIFFERENTIATION OF PC12 RAT PHEOCHROMOCYTOMA CELL-LINE. Oncology Reports. 1(4). 773–7. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Didier Grillot Breakdown of academic impact, for papers by Michèle Sabbah Breakdown of academic impact, for papers by Stavroula Baritaki Breakdown of academic impact, for papers by Françoise Porteu Breakdown of academic impact, for papers by Evelyn Orsó Breakdown of academic impact, for papers by Yoshimoto Katsura Breakdown of academic impact, for papers by Matthias Germer Breakdown of academic impact, for papers by Antonella Naldini Breakdown of academic impact, for papers by Sara Martínez‐Martínez Breakdown of academic impact, for papers by Xiyun Deng
Rankless by CCL
2026